22 Nov Dr. Jamie Falk: A Deep Dive into SGLT2 Inhibitors: What comes up to the surface for individual patients with diabetes?
In this engaging discussion lead by Dr. Jamie Falk, delivered at the Therapeutics Initiative at our Oct 16th conference, "Bringing Best Evidence to Clinicians", Jamie dove deep into a pool of relatively studies of the effects...